LOUIS DIVALENTIN
Allopathic & Osteopathic Physicians|Internal Medicine ANNISTON, AL NPI 1982625869
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine AL Paratek Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,135.93
- Category: General Payments
- Program years: PY2018–2024
- Record count: 47
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $245.56 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $245.56 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | $99.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $41.57 | 2 |
| Janssen Pharmaceuticals, Inc | $37.77 | 2 |
| ORGANOGENESIS INC. | $31.07 | 1 |
| Merck Sharp & Dohme Corporation | $19.05 | 1 |
| Solventum Corporation | $17.10 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077903297 | Janssen Pharmaceuticals, Inc | $20.83 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1077903317 | Janssen Pharmaceuticals, Inc | $16.94 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101329006 | E.R. Squibb & Sons, L.L.C. | $25.30 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101329088 | E.R. Squibb & Sons, L.L.C. | $16.27 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113897973 | Paratek Pharmaceuticals, Inc. | $99.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141660687 | Merck Sharp & Dohme LLC | $19.05 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144072787 | Solventum Corporation | $17.10 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145425748 | Organogenesis Inc. | $31.07 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.